Sun, Jan 25, 2015, 11:24 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ChromaDex Corporation Message Board

  • roxyroo73 roxyroo73 Dec 13, 2013 5:02 PM Flag

    Should North America let DSM buy CDXC?

    I'd rather it stay American and a bidding war would be nice to see too.
    Some scientist somewhere is going to influence a CEO to "get in there before anyone else".
    Or at least some of us can fantasize. I bet Dan would even give this a 5% chance of happening in 2014. I think either a buy-out or a huge contract is in order for 2014. Nobody will be able to wait for the results of all the studies, once they start rolling in, where one study solidifies another and another the NIAGEN foundation will be as strong and as popular as any new product can get. There are many studies occurring on NIAGEN as we speak in case you didn't know.

    NIAGEN offers a new pathway to NAD+, it's kind of pathetic humans have not been benifiting from this pathway for decades. This should have been discovered decades ago. No other product in the past 20 years has as much potential in my opinion.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CDXC
0.85-0.05(-5.55%)Jan 23 1:48 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.